ALDOB acts as a novel HBsAg-binding protein and its coexistence inhibits cisplatin-induced HepG2 cell apoptosis. [electronic resource]
Producer: 20150416Description: 181-91 p. digitalISSN:- 1045-4403
- Antineoplastic Agents -- pharmacology
- Apoptosis -- physiology
- Apoptosis Regulatory Proteins -- biosynthesis
- BH3 Interacting Domain Death Agonist Protein -- biosynthesis
- Bcl-2-Like Protein 11
- Carcinoma, Hepatocellular -- pathology
- Cell Line, Tumor
- Cisplatin -- pharmacology
- Fructose-Bisphosphate Aldolase -- genetics
- Glycogen Synthase Kinase 3 -- metabolism
- Glycogen Synthase Kinase 3 beta
- HEK293 Cells
- Hep G2 Cells
- Hepatitis B Surface Antigens -- metabolism
- Hepatitis B virus
- Hepatitis B, Chronic
- Humans
- Liver Neoplasms -- pathology
- Membrane Proteins -- biosynthesis
- Myeloid Cell Leukemia Sequence 1 Protein -- biosynthesis
- Phosphorylation
- Proto-Oncogene Proteins -- biosynthesis
- Proto-Oncogene Proteins c-akt -- metabolism
- RNA Interference
- RNA, Small Interfering
- bcl-2-Associated X Protein -- biosynthesis
- bcl-X Protein -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.